 Parenteral drug products aluminum ingredient contaminant response Food Drug Administration notice intent request information ASCN/A.S.P.E.N Group Standards Aluminum Content Parenteral Nutrition Solutions Aluminum significant contaminant total parenteral nutrition TPN solutions bone urine plasma infants TPN Aluminum accumulation tissues uremic patients adult TPN patients low-turnover bone disease Furthermore aluminum encephalopathy anemia uremic patients hepatic cholestasis experimental animals toxic effects aluminum Food Drug Administration FDA notice intent upper limit micrograms/L aluminum large-volume parenterals manufacturers small-volume parenterals calcium phosphate salts aluminum content note content package label ASCN/A.S.P.E.N Group Standards Aluminum Content Parenteral Nutrition Solutions intentions urges FDA cumulative aluminum intake terms safe unsafe toxic quantities aluminum kilogram physicians pharmacists TPN solutions manufacturers appropriate control procedures aluminum measurements standard unit aluminum measurement